A Multi-Concept Theme for Digital Agencies and Startups
The Ministry of Chemicals and Fertilizers has fixed the retail price in relation to the mentioned formulation with the unit and name of manufacturer & marketing company. i) Paracetamol + Phenylephrine + Caffeine+ Diphenhydramine Tablet ii) Gliclazide ER + Metformin ER Tablet iii) Chlorthalidone + Telmisartan + Amlodipine Tablet iv) Telmisartan + Cilnidipine Tablet v) Gliclazide + Metformin Hydrochloride (Sustained release) Tablet vi) Atorvastatin & Clopidogrel Capsule vii) Telmisartan, Cilnidipine & Metoprolol (ER) Tablets viii) Metformin + Glimepiride Tablet ix) Atorvastatin & Clopidogrel Capsule x) Diclofenac Tablet xi) Metformin + Glimepiride Tablet xii) Telmisartan + Amlodipine + Hydrochlorothiazide Tablet xiii) Paracetamol + Thiocolchicoside Tablet xiv) Pantaprozole Dualrelease Gastro-resistant tablet (Aristo Pantop 80) xv) Calcium, Vitamin D3, Mecobalamin, LMethylfolate Calcium & Pyridoxal-5-Phosphate Tablet xvi) Diclofenac Transdermal Patch xvii) Diclofenac Diethylamine + Methyl Salicylate + Menthol topical Spray xviii) Paracetamol Infusion Further, as per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises.
Request a Demo
CDSL has reiterated the SEBI Circular on the norms for sharing and usage of price data for educational purposes, effective from July 01, 202
CDSL has issued a communique on the incorporation of Lock-In of Pre-Issue Capital during Initial Public Offering. Through this communique,
CDSL has reiterated the SEBI circular on the Fast-Track Mechanism for Processing of Placement Memorandum of AIFs filed with SEBI (“PaR
CDSL has reiterated the SEBI circular on the operationalisation of Past Risk and Return Verification Agency (“PaRRVAâ€). Key hig
7
I
2
Thank You for your interest in Complinity. Your CV has been forwarded to HR. In case your profile is shortlisted, HR shall contact you.